Purpose: Intraocular pressure (IOP) is the primary risk factor for developing glaucoma. 27 The present study examines genomic contribution to the normal regulation of IOP in the 28 mouse. 29 30 Methods: The BXD recombinant inbred (RI) strain set was used to identify genomic loci 31 modulating IOP. We measured the IOP from 532 eyes from 33 different strains. The IOP 32 data will be subjected to conventional quantitative trait analysis using simple and 33 composite interval mapping along with epistatic interactions to define genomic loci 34 modulating normal IOP. 35
3 Introduction 49
Glaucoma is a diverse set of diseases with heterogeneous phenotypic presentations 50 associated with different risk factors. Untreated, glaucoma leads to permanent damage of 51 axons in the optic nerve and visual field loss. Millions of people worldwide are affected 52 [1, 2] and it is the second leading cause of blindness in the United States [3] . Adult-onset 53 glaucoma is a complex collection of diseases with multiple risk factors and genes with 54 differing magnitudes of effects on the eventual loss of RGCs. The severity of the disease 55 appears to be dependent on the interaction of multiple genes, age, and environmental 56 factors [4] . There are also a number of phenotypic risk factors for POAG including: age, 57 ethnicity, central corneal thickness and axial length [5] . The primary risk factor is an 58 elevated intraocular pressure (IOP) [6] . There are known genetic mutations that affect 59 IOP that result in inherited glaucoma [7, 8] . The prime example is MYOC, a protein 60 secreted by the trabecular meshwork and mutations in this protein cause ER stress which 61 results in a decrease in the function of the trabecular meshwork and an elevation in IOP 62 [9, 10] . We know a considerable amount about the regulation of IOP from the production 63 of aqueous humor to the outflow pathways. IOP is a complex trait affected by different 64 tissues in the eye each of which is regulated by multiple genomic loci. Interestingly, 65
there are very few studies that have identified genomic loci modulating normal IOP. 66
67
In the present study, we are using the BXD RI strain set that is particularly suited for the 68 study of genetics and the effects on the severity of glaucoma. This genetic reference 69 panel presently consists of 80 strains [11] , and we are now in the unique position of being 70 able to study the eyes of more than 80 strains with shuffled genomes from the two 71 parental strains, C57BL/6J and the DBA/2J. There are over 7,000 break points in our 72 current set of BXD strains. For this study, our group has measured IOP of 532 eyes from 73 33 strains to identify genomic loci modulating IOP. A systems genetics approach to 74 glaucoma is a relatively new branch of quantitative genetics that has the goal of 75 understanding networks of interactions across multiple levels that link DNA variation to 76 phenotype [12] . Systems genetics involves an analysis of sets of causal interactions 77 among classic traits such as IOP, networks of gene variants, and developmental, 78 environmental, and epigenetic factors. The main challenge is the need for comparatively large sample size and the use of more advanced statistical and computational methods 80 and models. We finally have a sufficiently large number of strains to use this approach 81 [13, 14] . Our goal is now to combine data across several levels from DNA to ocular 82 phenotype and analyze them with newly developed computational methods to understand 83 pre-disease susceptibility to glaucoma along with the genetic networks modulating the 84 response of the eye to elevated IOP. 85 86 87
Methods 88
Mice: This study measured the IOP in the 33 BXD strains of mice along with the parental 89 strains the C57BL/6J mouse strain and the DBA/2J mouse strain. None of the BXD 90 strains included in this study carried both mutations (Tyrp1 and Gpnmb) known to cause 91 the severe glaucoma phenotype observed in the DBA2/J strain. All of the mice in this 92 study were between 60 and 120 days of age, a time before there is any significant 93 elevation in IOP due pigment dispersion [15] . The data presented in this paper is based on 94 measurements from 532 eyes with roughly equal numbers of male and female mice. All 95 breeding stock was ordered from Jackson Laboratories (Bar Harbor, ME) and maintained 96 at Emory. Mice were housed in the animal facility at Emory University, maintained on a 97 12 hr light/dark cycle (lights on at 0700), and provided with food and water ad libitum. 98 IOP measurement were made between 0900 and 1100. Both eyes were measured and the 99 data from each eye was entered into the database. An induction-impact tonometer 100 (Tonolab Colonial Medical Supply) was used to measure the IOP according to 101 manufacturer's instructions and as previously described (Saleh M, Nagaraju M, Porciatti 102 2007; Nagaraju M, Saleh M, Porciatti V 2009). Mice were anesthetized with Avertin (334 103 mg/kg) or ketamine/xylazine (100,15mg/kg). Three consecutive IOP readings for each 104 eye were averaged. IOP readings obtained with Tonolab have been shown to be accurate 105 and reproducible in various mouse strains, including DBA/2J (Wang et al., 2005) . All 106 measurements were taken approximately 10 minutes after the induction of anesthesia. 107
These IOP measurements were made on mice prior to two different experimental 108 procedures, blast injury to the eye or elevation of IOP by injection of magnetic beads into 109 the anterior chamber. When we compared the IOP of animals anesthetized with Avertin to those anesthetized with ketamine/xylazine over the entire dataset there was not 111 significant difference between the two groups. We did a similar comparison looking only 112 at the C57BL/6J mice with 11 mice anesthetized with Avertin (mean IOP 10.2, SD 0.15) 113 and 27 mice anesthetized with ketamine/xylazine (mean IOP 11.2, SD 2.9) and there was 114 no statistically significant difference between the two groups using a student t-test. . We correlate 121 phenotypes with expression data for whole eye and retina generated [13, 20, 21] . 122 123 Immunohistochemistry: For immunohistochemical experiments mice were deeply 124 anesthetized with a mixture of 15 mg/kg of xylazine (AnaSed) and 100 mg/kg of 125 ketamine (Ketaset) and perfused through the heart with saline followed by 4% 126 paraformaldehyde in phosphate buffer (pH 7.3). The eye were embedded in paraffin as 127 described by Sun et al., [22] . The eyes were dehydrated in a series of ethanol and xylenes 128 changes for 20 minutes each (50% ETOH, 70% ETOH, 90% ETOH, 95% ETOH, two 129 changes of 100% ETOH, 50% ETOH with 50% xylenes, two changes of 100% xylenes, 130 two changes of paraffin. The eyes were then embedded in paraffin blocks. The eyes were 131 sectioned with a rotary microtome at 10µm and mounted on glass slides. The sections 132
were deparaffinized and rehydrated. The sections were rinsed in PBS, and then placed in 133 blocking buffer containing 2% donkey serum, 0.05% DMSO and 0.05% Triton X-100 for 134 30 min. The sections were rinsed in PBS, and then placed in blocking buffer containing 2% 135 donkey serum, 0.05% DMSO and 0.05% Triton X-100 for 30 min. The sections were 136 incubated in primary antibodies (1:500) against Cadherin 11 (Thermofisher, Cat. #71-137 7600, Waltham, MA) overnight at 4°C. After rinsing, the sections were incubated with 138 secondary antibody conjugated to AlexaFluor-488 (donkey anti-rabbit, Jackson 139
Immunoresearch Cat #711-545-152, Westgrove, PA) , (1:1000), for 2 hours at room 140 temperature. The sections were then rinsed 3 times in PBS for 15 minutes each. Then they were counterstained with TO-PRO-3 iodide was purchased from Invitrogen (T3605,  142 Invitrogen, Eugene OR). The slides were flooded with Fluoromount-G (SouthernBiotech 143 Cat #. 0100-01, Birmingham, AL), and covered with a coverslip. All images were 144 photographed using on Nikon Eclipse TE2000-E (Melville, NY) confocal and images 145 were acquired by Nikon's EZ-C1 Software (Bronze Version, 3.91). The overall goal of the present investigation was to determine if specific genomic loci 164 modulate IOP in the BXD RI strains. IOP was measured in 532 eyes form 33 BXD RI 165 strains and the two parental strains C57BL/6J mouse and DBA2/J mouse. To create a 166 mapping file the strain averages and standard errors were calculated (Figure 1 ). The IOP 167 measured across the 33 strains was 13.2 mmHg and the standard deviation was 1.5 168 mmHg. The strain with the lowest IOP was DBA2/J, with an average IOP of 10.9 mmHg. 169
The strain with the highest IOP was BXD48 with an average IOP of 17.1 mmHg. The 170 IOP of the parental strains was 11.6 mmHg for the C57BL/6J and 10.9 mmHg for the set. This type of phenotypic variability is a clear indication that IOP is in fact a complex 173 trait. These data can also be used to calculate the heritability of IOP. Figure 1 reveals a  174 considerable variability in the IOP from strain to strain and the standard error for each 175 strain is rather small. This type of data suggests that the genetic variability has a greater 176 effect than the environmental variability. These data can be used to calculate the 177 heritability of IOP. To calculate heritability (H 2 ) is the genetic variance (Vg) of the trait is 178 divided by the sum of genetic variance plus the environmental variance (Vg +Ve). The 179 genetic variance can be estimated by taking the standard deviation of the mean of IOP for 180 each strain (Vg = 1.5 mmHg). The environmental variance can be estimated by taking the 181 mean of the standard deviation across the strain (Ve = 3.3 mmHg). Using the formula for 182 heritability, H 2 = Vg/(Vg + Ve), the calculation of 1.5 mmHg /(1.5 mmHg + 3.3 mmHg) 183 reveals that H 2 = 0.31.6. Thus, IOP is a heritability trait in the BXD RI strain set. Cdh11 is expressed at levels higher than the mean and Cdh8 is expressed at levels below 212 the average expression level. Furthermore, in the whole eye database, there is over an fold increase in expression of Cdh11 relative to Cdh8. In the retina database, Cdh11 214 (probe set 17512153) had an expression level of 10.9 and Cdh8 (probe set 17512121) had 215 an expression level of 9.3, indicating that within the retina proper Cdh11 is expression is 216 2-fold higher than Cdh8. 217
218
To confirm the expression levels of Cdh11 and Cdh8 in the eye, we examined the levels 219 of mRNA in the whole eye by RT-qPCR. In 4 biological replicate RNA samples, we 220 examined the levels of Cdh11, Cdh8 and Myoc (a marker of trabecular meshwork cells, 221
[23]). Our PCR analysis confirmed the general findings of the microarray data sets. In 222 the 4 biological samples of whole eye, Cdh11 was more highly expressed than Cdh8. The 223 average of the 4 samples demonstrated a more than 2-fold higher expression of Cdh11 224 than Cdh8. Myoc was also expressed at a higher level than Cdh8 but at approximately at 225 the same level as Cdh11. All of these data taken together indicate that Cdh11 is the prime 226 candidate for an upstream modulator of IOP. 227 228 Distribution of Cadherin 11 in the Eye: To determine if cadherin 11 is found in 229 structures associated with the control of IOP, we stained sections of the eye for cadherin 230 11. In these sections, there was a considerable amount of antibody-specific staining (Fig.  231   4A ). This label is not observed in control sections stained with secondary antibody only 232 ( Fig. 4B ). There is extensive labeling of all layers of the cornea. The epithelium of the ciliary body is also heavily labeled as well as labeling of pars plana. There is also light 234 labeling of the retina. At higher magnification (Fig. 4C) , clear labeling of the trabecular 235 meshwork (arrow). Thus, cadherin 11 is expressed in the cells of the trabecular 236 meshwork, the primary structure involved in regulating IOP. 237 238 239
Discussion 240
The normal regulation of intraocular pressure is a balance between production in the 241 ciliary body and outflow [24, 25] . In the human, IOP ranges can range from a relatively 242 low pressures to extremely high that occur in acute angle closure glaucoma. It is 243 generally accepted that the "normal" range for IOP in humans is from 12mmHg to 244 22mmHg [26, 27] . In addition, monitoring throughout the day reveals IOP is pulsatory 245 and has a diurnal variability [28] . These findings tell an interesting story about the 246 regulation of pressure in the eye; however, the primary driving force behind the intense 247 investigation of IOP in humans is that fact that it is the primary risk factor for developing 248 glaucoma [29] . Furthermore, all of the current treatments for glaucoma center around 249 lowering IOP either by pharmacological approaches or surgery [30, 31] . 250
251
The association of elevated IOP and glaucoma, has driven most of the study of IOP in 252 human populations [5, 32, 33] . Most of these studies involve the study of glaucoma, but 253 a few have a primary focused on the regulation of IOP. These studies have found that 254 IOP is a heritable trait with estimates of heritability ranging from 0.39 to 0.64 [6, [34] [35] [36] . 255
In the present study, we found that the heritability of IOP in the BXD RI strains was 0.36. 256
Thus, the mouse strains demonstrated a heritability near the lower end of the human 257 populations. The interest has prompted studies to identify genes regulating IOP. In a 258 genome-wide association study of IOP involving 11,972 subjects, significant associations 259 were observed with SNPs in two genes, GAS7 and TMCO1 [37]. Both of these genes are 260 expressed at high levels in the ciliary body and trabecular meshwork [38] and both of the 261 genes interact with known glaucoma risk genes [37] . TMCO1 is also known to be 262 associated with sever glaucoma risk [39] . 263
In an effort to understand the regulation of IOP and its effects on the retina, many 265 research groups have used inbred mouse strains [40] [41] [42] [43] [44] . IOP varies widely across 266 different strains of mice [40, 45] , ranging from a low of 11mmHg in the BALB/c mouse 267 strain to a high of 19mmHg in the CBA/Ca mouse strain. In the present study, the 268 average measured IOP across the 33 strains was 13.2mmHg. The lowest measured IOP 269 was 10.9mmHg in the DBA/2J strain and the highest was 17.1mmHg in the BXD48 270 strain. Using the variability across the BXD RI strains we were able to map a single 271 significant QTL on Chr. 8 in the mouse. The peak of the QTL was in a gene desert and 272 within this region there were only two potential candidate genes that could be modulating 273 IOP in the BXD strain set. Based on expression of mRNA in the eye microarray dataset 274 and the findings of real time PCR Cdh11 appears to be the best candidate. Cdh11 is 275 expressed approximately 8-fold higher in the eye than is Cdh8. Furthermore, previous 276 study [46] found CDH11 to be highly expressed in cultured human trabecular meshwork 277 cells. We found that Cadherin 11 is expressed in the trabecular meshwork using indirect 278 immunohistochemistry. All of these data suggest that the expression Cadherin 11 in the 279 trabecular meshwork modulates IOP across the BXD RI strain set. 280
281
How is it possible that a cadherin can modulate IOP in the mouse eye? IOP is regulated 282 by fluid resistance at the trabecular meshwork and Schlemm's canal [47, 48] . The 283 stiffness of these structures is determined by the extracellular matrix within the trabecular 284 meshwork and Schlemm's canal and the contractile nature of the cells themselves (Zhou 285 et al. 2012) inner wall was considered to be the most important player regulating such 286 resistance [49] [50] [51] . The dysregulation or poor organization of extracellular matrix may 287 increase the fluid resistance, leading to an elevation of the IOP. Cdh11 was recently 288 revealed to be a novel regulator of extracellular matrix synthesis and tissue 289 mechanics [52] , and it is also found to be highly expressed in cultured human trabecular 290 meshwork cells [46] . It is possible that the IOP can be regulated by Cdh11 and related 291 pathways by altering the extracellular matrix structure of the trabecular meshwork. Future 292 studies about the role of Cdh11 in the trabecular meshwork may give insights into the 293 mechanism of IOP modulation. 294 296 297 298 Acknowledgements: We would like to thank the Robert W Williams and his group for 299 providing a wealth of bioinformatic resources on GeneNetwork.org. We thank Chelsey 300
Faircloth for her assistance in immunostaining. This study was supported by an 301 3 . The interval map for Chr. 8: 90 to 120Mb is illustrated. A is the gene tract, that 519 identifies the locations of known genes across the genome. B is a haplotype map for the 520 different BXD RI strains listed to the right and ranked from the highest IOP to the lowest 521 IOP. The location of genomic markers is indicated by black vertical lines. C is an 522 expanded version of the interval map for IOP. Finally, the bottom trace (yellow) 523 identified the location of SNPs between the C57BL/6 mouse and the DBA2/J mouse. The 524 genomic location is indicated along this lower trace. Notice that the peak of the QTL in C 525 sits in a region of the genome that contains very few known genes (A). 526 527 528 529 530 531 532 533 534 Figure 4 . The distribution of cadherin 11 in the limbal area of the eye is illustrated. The 535 section in A was stained with an antibody specific to cadherin 11 (green) and for DNA 536 (blue). This staining is specific to the primary antibody for it is not observed in a section 537 stained with the secondary antibody alone (B). The staining pattern of the trabecular 538 meshwork is shown at higher magnification in C (arrow 
